Rpg Life News

RPG Life Sciences is expanding its API business after two acquisitions totaling ₹215 crore, increasing its manufacturing capacity fivefold and strengthening its

RPG Life Sciences has invested ₹215 crore in two acquisitions within five weeks, aiming for significant API expansion and plans to deploy an additional ₹500-700

RPG Life Sciences is investing in building a drug-ingredients business, anticipating that the global shift away from reliance on China will benefit Indian manuf

RPG Life Sciences plans to invest Rs 500 crore over the next 12 months to enhance its manufacturing and API capabilities through strategic acquisitions. The com

RPG Life Sciences' subsidiary, RPG Active Pharma, is acquiring Raghava Life Sciences' API and intermediates business for Rs 135 crore. This strategic acquisitio

RPG Life Sciences has partnered with Archerchem Healthcare to launch a new anti-inflammatory medication with gastroprotection in India, with RPG Life Sciences h